Back to school on APS: Rethinking the risk of recurrent stroke in children

Neurology

Volumn 62, Issue 2, 2004, Pages 172-173

  Fullerton, Heather J ^a   Von Scheven, Emily ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CHILD; DISEASE ASSOCIATION; EDITORIAL; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; STROKE;

EID: 0842282477     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.62.2.172     Document Type: Editorial

References (6)

1. Nestoridi E, Buonanno FS, Jones RM, et al. Arterial ischemic stroke in childhood: the role of plasma-phase risk factors. Curr Opin Neurol 2002;15:139-144.
2. deVeber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998;55:1539-1543.
3. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283-1288.
4. Strater R, Vielhaber H, Kassenbohmer R, et al. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999;158(suppl 3):S122-125.
5. Brey RL, Chapman J, Levine SR, et al. Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus 2003;12:508-513.
6. Lanthier S, Kirkham FJ, Mitchell LG, et al. Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children. Neurology 2004;62:194-200.